Ansan-si, South Korea

Hong-Woo Lee




Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2004-2012

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Hong-Woo Lee

Introduction

Hong-Woo Lee is a prominent inventor based in Ansan-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for synthesizing important compounds. With a total of 2 patents to his name, Lee's work has had a notable impact on the industry.

Latest Patents

One of his latest patents is titled "Method for the preparation of atorvastatin and intermediates used therein." This invention relates to a novel method for preparing atorvastatin, a medication used to lower cholesterol. The patent describes a new intermediate for the preparation of atorvastatin and outlines a method for producing large quantities of the drug safely using this intermediate. Another significant patent is for "Thiazolidinedione derivatives and pharmaceutical composition comprising the same," which focuses on the development of new pharmaceutical compounds.

Career Highlights

Hong-Woo Lee is currently associated with Chong Kun Dang Pharmaceutical Corporation, a leading company in the pharmaceutical industry. His work at the company has allowed him to contribute to the advancement of drug development and production processes.

Collaborations

Lee has collaborated with notable colleagues, including Soon Kil Ahn and Choong Leol Yoo, who have also made significant contributions to the field of pharmaceuticals.

Conclusion

Hong-Woo Lee's innovative work in the pharmaceutical sector, particularly in the synthesis of atorvastatin and thiazolidinedione derivatives, showcases his expertise and dedication to advancing medical science. His contributions continue to influence the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…